Clinical Trial Update: Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 trial updating early administration of edoxaban after acute ischemic stroke in patients with non-valvular atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Jong Sung Kim | Conditions: Acute Ischemic Stroke | Phase 2 | Status: COMPLETED